HPV vaccine production delayed due to COVID focus, supply in India to begin in early 2023: Serum Institute
.
news
2022-10-21 06:48:08

Image used for representation purpose only.
| Photo Credit: AP
Serum Institute of India (SII) had to defer HPV vaccine production by two years due to the focus on COVID-19, and will start supplying small quantities of the dose to the Central government in early 2023, a top official has said.Exports will have to wait till 2024, its chief executive Adar Poonawalla told reporters in Pune on Thursday evening, adding that the company has to build a scale of manufacturing to over 150 million for that.Also Read | India-made HPV vaccine to cost â‚¹200HPV vaccines prevent certain kinds of cervical cancer.
